Ligand-based drug design combines AI and QSAR modeling to prioritize drug candidates, minimizing preclinical failures and ...
The business practice of adjusting prices using algorithms powered by artificial intelligence—known as AI pricing—has grown ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results